Breaking Finance News

Zacks Investment Research upgraded Addus Homecare Corporation (NASDAQ:ADUS) to Hold in a statement released earlier today.

Zacks Investment Research has upgraded Addus Homecare Corporation (NASDAQ:ADUS) to Hold in a statement released on 10/04/2016.

Boasting a price of $26.04, Addus Homecare Corporation (NASDAQ:ADUS) traded 0.04% higher on the day. The last stock close price is up 28.17% from the 200-day moving average, compared with the S&P 500 Index which has decreased -0.01% over the same time. The company has recorded a 50-day average of $24.14 and a two hundred day average of $20.32. 37,627 shares of ADUS traded hands, down from an average trading volume of 54,975

Recent Performance Chart

Addus Homecare Corporation (NASDAQ:ADUS)

Addus Homecare Corporation has 52 week low of $15.33 and a 52 week high of $38.08 with a P/E ratio of 32.23 and has a market cap of $0.

About Addus Homecare Corporation (NASDAQ:ADUS)

Addus HomeCare Corporation is a provider of home and community-based personal care services, which are provided primarily in the home, and is focused on the dual eligible (Medicare/Medicaid) population. The Company's services include non-medical care, such as personal care, home support services and adult day care. The Company provides these services on a long-term, continuous basis, with an average duration of over 20 months per consumer. The Company's services are primarily provided to older adults and younger disabled persons in consumers' homes on an as-needed, hourly basis. The Company's personal care services include bathing, grooming, oral care, skincare, assistance with feeding and dressing, and medication reminders. The Company's adult day centers offer services, such as social activities, transportation services to and from the centers, the provision of meals and snacks, personal care and therapeutic activities, such as exercise and cognitive interaction.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.